Investors Shrug Off Good News for Heart Patients From New Meds — Barrons.com

By Bill AlpertThis year's run in drug stocks gained vigor from new treatments for heart attacks and strokes. Maybe some of those stocks are losing wind.At this past weekend's congress of the European Society of Cardiology, in Munich, good results came out on drugs from Amgen, Arrowhead Pharmaceutic…